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established by the Brazilian government (2.5-6.5%) and below the observed mean
rate in the last three years (4.4%).
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OBJECTIVES: The aim of this paper is to present a compact and coherent within the
Bayesian inference method of best meta-analysis model selection as well as to
present analytical results in performing Gibbs sampling within the MTC
framework. METHODS: In order to perform Gibbs sampling from the posterior
distribution in the random effects model of MTC we evaluate the formulas for the
conditional distributions for all parameters. We test for the existence of between
study heterogeneity and other parametric restrictions by comparing marginal data
densities of competing models. We show how the prior distribution on the model
space may affect the inference about best model selection. As an empirical exam-
ple we present an analysis of effectiveness of two real (although blinded) drugs and
placebo. RESULTS: We present the marginal posterior distributions of key param-
eters as well as the comparison of a few restricted models. Among 18 studies from
the systematic review dealing with treating the analyzed medical issue with drugs
of interest there exist a significant effect of heterogeneity. The a priori distribution
on the space of models does not affect this final conclusion (Bayes factor varies
from 185 to 190 in favor of the unreduced model). The posterior odds ratio (which
equals around 293.1) points that the treatment with Medicine A brings a stronger
effect than with Medicine B or placebo. CONCLUSIONS: Our results show, that
using pure Bayesian techniques can be widely used within the MTC framework. We
present an easy to operate and coherent inference in performing complex meta-
analyses. We also found confirmed, that Medicine A significantly better increases
the level of observed outcome than other treatments.
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OBJECTIVES: To translate, validate and examine the psychometric properties of
the Urdu version of the Morisky Medication Adherence Scale (MMAS) among pa-
tients with hypertension. METHODS: A systematic procedure of ‘‘forward–back-
ward’’ was used to translate MMAS into Urdu (official language of Pakistan). It was
later validated on a convenience sample of 272 established hypertensive patients
between July and October 2010 visiting outpatient department of cardiac ward at
Bolan Medical College Hospital, Quetta, Pakistan. For test-retest reliability, data
was available for 42 patients. Internal consistency was taken as a measure to test
reliability of the MMAS. Convergent and known group validity was taken into ac-
count to confirm the validity. RESULTS: The mean SD of MMAS score was 6.19
1.81, which was measured by applying the recommended scoring method of
Morisky Scale. Internal consistency was found to be moderate (Cronbach’s a 
0.621). Test–retest reliability value was 0.801 (p  0.001). By applying Spearman’s
rho, positive correlation between the eight- and four item MMAS was found (r 
0.792; p  0.01). A significant relationship between MMAS categories and blood
pressure control (2 20.121; p0.001) was found. The MMAS sensitivity and spec-
ificity, with positive and negative predictive values were 71.54%, 41.48%, 44.74%
and 75.56%, respectively. CONCLUSIONS: The findings of this validation study in-
dicate that the Urdu version of the MMAS is a reliable and valid tool for the mea-
surement of medication adherence in Pakistani health system.
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OBJECTIVES: PatientsLikeMe developed the 24-item PLMQOL to be a brief, easy-to-
complete online patient-reported assessment of health-related quality of life. The
instrument consists of three domains: physical, social, and mental function. As
part of the validation process, we examined the performance of the PLMQOL com-
pared with the RAND SF-36 in a population of patients with chronic disease.
METHODS: Both the PLMQOL and the RAND SF-36 were administered via internet
to 2042 invited members of PatientsLikeMe, a novel health data-sharing website
allowing patients to monitor multidimensional aspects of health and well-being.
Patients were randomized to questionnaire order and were required to have filled
out at least one PLMQOL in the 30 days prior to the Jun 9, 2011 survey deployment
date in order to be eligible. RESULTS: 1228 patients opened the survey invitation,
and 660 (54% of those who opened the invite; 32% of eligible sample) patients
completed the survey over the 10-day window of availability. No significant differ-
ences were seen between the randomized samples by age, sex, condition, or re-
sponse. Respondents represented approximately 100 chronic conditions; most
commonly reported were multiple sclerosis (n147), fibromyalgia (n112), Parkin-
son’s disease (n43), and amyotrophic lateral sclerosis (n42). The PLMQOL dem-
onstrated high reliability across domains of physical (11 items, 0.940-0.944),
mental (8 items, 0.909-0.917, and social function (5 items, 0.810-0.828). In
addition, the PLMQOL was highly correlated with relevant domains of the RAND
SF-36 as demonstrated by Pearson correlation: RAND physical function and
PLMQOL physical function (r0.838-0.855, p0.001); RAND emotional well-being
and PLMQOL mental function (r0.832-0.852, p0.001); RAND social function and
PLMQOL social function (r0.795-0.823, p0.001). CONCLUSIONS: The PLMQOL is a
reliable and valid instrument for online assessment of health-related quality of life,
demonstrating high correlations with relevant domains of the RAND SF-36. Further
research is required to assess disease-specific psychometric properties and clinical
validity.
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OBJECTIVES: This analysis describes the development, application and compari-
son of three different equivalence approaches to evaluate equivalence properties
of a patient reported outcome (PRO) questionnaire applied to two treatment groups
for gastroesophageal reflux disease (GERD). The data used in this analysis was
obtained from a medication-monitoring disease registry (iGuard). Patients using
either of the two treatments were randomly invited to complete a measure of
treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication
(TSQM). METHODS: Three statistical applications of Confirmatory Factor Analysis
(CFA) using a special case of Structural Equation Modelling (SEM) were used to
evaluate the equivalence of the TSQM in the two patient populations: 1) equality of
the factor scores (measurement equivalence); 2) equality of the variance-covari-
ance matrix (structural equivalence); 3) equality of the measurement error (reli-
ability equivalence). RESULTS: Each statistical test agreed that equivalence had
been achieved between the two treatment populations for all the three domains of
the TSQM. The effectiveness and global satisfaction domains exhibited the stron-
gest significant results on all three tests. However, while the convenience domain
exhibited strongly significant equivalence for the measurement equivalence, it
only exhibited significant results for the structural and reliability equivalence.
CONCLUSIONS:While all three methods indicated the same overall results, there is
some suggestion of differing sensitivity amongst the tests.
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OBJECTIVES: In economic evaluation patient-reported questionnaires are fre-
quently used for data collection on medical consumption and productivity losses.
The TiC-P is a comprehensive questionnaire focused on establishing costs incurred
within the health care system and costs arising from production losses. The ques-
tionnaire was developed for a broad application of collecting data in patients
treated in mental health care. The aim of this study is to assess the questionnaire’s
feasibility and validity. METHODS: Validation included feasibility, consistency
(test-retest) and reliability of reported data. Data were derived from a number of
patients included in a study evaluating the cost-effectiveness of alternative feed-
back mechanisms during psychotherapy. Consistency of the data was assessed
using Cohen’s kappa coefficients (categorical variables) and intraclass correlation
coefficients (ICC) (measurements on interval level). The following values were at-
tached to the coefficients: modest (0.21-0.40); moderate (0.41-0.60); satisfactory
(0.61-0.80) and almost perfect (0.81-1.00). Reliability was assessed comparing re-
ported data with registered contacts with psychiatrist, psychologist or psychother-
apist. Feasibility was based on response rate, and completeness of report on
medication. RESULTS: Re-test analyses were based on retest questionnaires of 99
respondents. Agreement regarding medical services was as follows: moderate: 3
items; satisfactory: 8 items; almost perfect: 1 item. Categorical items related to
productivity losses included short-term and long-term absence from work and
impediment at work. Agreement on these items was satisfactory. ICC’s were cal-
culated for 7 items presenting the number of contacts with health care providers.
For the remaining items on medical services, ICC’s could not be assessed due to
insufficient variation in the data. Agreement was considered modest on 1 item,
satisfactory on 3 items and almost perfect on 3 items. Reliability of reported and
registered number of contacts was 82%. CONCLUSIONS: These preliminary results
indicated that the TiC-P is a valid instrument for measuring medical consumption
and productivity losses.
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OBJECTIVES: The objective is to identify published studies reporting utility values
or preferences for health states elicited from the Spanish population with the
long-term purpose of maintaining an updated database of utilities that can be of
help for the research community. METHODS: A systematic review was conducted
to identify studies that elicited utilities by means of questionnaires validated in
Spain (EQ-5D, SF-6D, etc.) or accepted techniques (time trade-off, standard gamble,
etc.), from healthy or non-healthy populations. We initially focused in cancer,
diabetes and heart diseases. An electronic search was developed and run in MED-
LINE, EMBASE, PsycINFO, NHS CRD, Cochrane Central Register of Controlled Trials,
CINAHL and Spanish databases. Original utility sources were identified from clin-
A426 V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) A 2 3 3 - A 5 1 0
